[Disclosure] Alteogen(196170) Anticipated for ‘Investment Warning’ Designation and Designated as ‘Investment Caution’ Stock Due to Over 200% Surge in a Year

Source Fact: Financial Supervisory Service DART / 2024-11-08

Disclosure Type: Anticipated Designation of Investment Warning Stock (Designation of Investment Caution Stock)

💡 3-Second Summary

Due to a massive surge of over 200% compared to its stock price a year ago and a high level of buy involvement from specific accounts, biotech firm Alteogen has been issued a preliminary warning for ‘Investment Warning Stock’ designation and will be classified as an ‘Investment Caution Stock’ for one day on November 11.

📊 1. [Summary of Core Disclosure Content and Major Figures]

• Target Stock: Alteogen Co., Ltd. Common Stock (Ticker: 096170)
• Anticipated Date of Caution Designation: November 11, 2024 (Designated as an Investment Caution Stock for 1 day)
• Reason for Preliminary Warning: The closing price on November 08, 2024, surged by more than 200% compared to the closing price from one year ago, satisfying the conditions for long-term price appreciation and highly concentrated account involvement.
• Conditions for Final ‘Investment Warning Stock’ Designation: During the 10 trading days from November 11, 2024, to November 22, 2024, if all the following three conditions are met on any specific judgment day (T), the stock will be designated as an Investment Warning Stock on the following day:
  1. The closing price on the judgment day (T) is at least 200% higher than the closing price from one year ago.
  2. The closing price on the judgment day (T) is the highest among the closing prices of the past 15 consecutive trading days (including day T).
  3. The number of days where the trading volume involvement rate of the top 10 accounts (considering market impact over the past 15 days) meets the regulatory threshold is 4 days or more.
• Note on Schedule: The primary judgment date begins on November 11, 2024. If the criteria are not met, the judgment period rolls forward daily until November 22, 2024. The schedule may change if trading of the stock is suspended.
• Governing Regulation: Article 5-3 of the Market Surveillance Regulation and Article 3-3 of the Enforcement Rules of the same regulation.

📈 2. [Expert View: What This Disclosure Means for Investors]

This disclosure represents a regulatory market warning mechanism triggered by the Korea Exchange (KRX) to curb overheating and protect investors following a prolonged and sharp increase in Alteogen’s stock price. It is a procedural action based on market trading dynamics rather than an announcement concerning the company’s fundamental business changes, financial earnings, or pipeline advancements.

The preliminary warning may serve as a short-term cooling factor for market psychological sentiment. If the stock price continues to climb during the evaluation window (November 11 to November 22) and meets all regulatory criteria, a formal upgrade to an “Investment Warning Stock” could materialize. Under the KRX market warning system, advancing to the Investment Warning or Investment Risk stages can lead to potential temporary trading suspensions. Therefore, investors may need to closely evaluate subsequent stock price movements and changes in account trading concentrations rather than interpreting this as a guaranteed direction for future returns.

📝 Editor’s Comment (by K-STOCK Editor)

Applied Comment Style: Cautionary View

Alteogen’s relentless rally has ultimately landed it on the exchange’s radar. While a 200% year-on-year surge proves the overwhelming market interest, it has simultaneously triggered the ‘ultra-long-term rise and concentrated account activity’ condition, with the top 10 accounts heavily driving buy orders. As it steps into the ‘Investment Caution’ status on November 11, intraday volatility is highly likely to increase. Given the potential risk of being upgraded to an ‘Investment Warning Stock’ depending on how the closing price prints every day until November 22, investors might want to distance themselves from FOMO and adopt a disciplined approach to observe how the regulatory parameters unfold.

📢 Disclaimer and Source Information

Source: This content has been structured and newly written based on the official data submitted to the Electronic Disclosure System (DART) of the Financial Supervisory Service.

Investment Risk Notice: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Inquiries: For compliance-related inquiries or copyright requests, please contact ksb220805@gmail.com.